Earnings call BeautyHealth's Q4 revenue declined 1.3% YoY to $82.4M, but adjusted EBITDA rose to $15M (up from $9M), and gross margins improved on a favorable revenue mix. Management guides for flat ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果一些您可能无法访问的结果已被隐去。
显示无法访问的结果